WEKO3
アイテム
{"_buckets": {"deposit": "2baf5f8c-5574-4ab5-b555-4d440446b5b5"}, "_deposit": {"created_by": 1, "id": "47199", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "47199"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00047199", "sets": ["1"]}, "author_link": ["471693", "471694", "471696", "471691", "471692", "471700", "471702", "471698", "471697", "471701", "471690", "471704", "471699", "471706", "471695", "471705", "471703"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "175", "bibliographicPageStart": "169", "bibliographicVolumeNumber": "28", "bibliographic_titles": [{"bibliographic_title": "Movement Disorders"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer\u0027s disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson\u0027s disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini\u0026#8211;Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition.", "subitem_description_type": "Abstract"}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "http://doi.wiley.com/10.1002/mds.25286"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://doi.wiley.com/10.1002/mds.25286", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0885-3185", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Shimada, Hitoshi"}], "nameIdentifiers": [{"nameIdentifier": "471690", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shinoto, Hitoshi"}], "nameIdentifiers": [{"nameIdentifier": "471691", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirano, Shigeki"}], "nameIdentifiers": [{"nameIdentifier": "471692", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fukushi, Kiyoshi"}], "nameIdentifiers": [{"nameIdentifier": "471693", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Irie, Toshiaki"}], "nameIdentifiers": [{"nameIdentifier": "471694", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ito, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "471695", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Higuchi, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "471696", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suhara, Tetsuya"}], "nameIdentifiers": [{"nameIdentifier": "471697", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "471698", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "島田 斉", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471699", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "篠遠 仁", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471700", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "平野 成樹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471701", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "福士 清", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471702", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "入江 俊章", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471703", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "伊藤 浩", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471704", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "樋口 真人", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471705", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "須原 哲也", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "471706", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Beta-Amyloid in Lewy body disease is related to Alzheimer\u0027s disease-like atrophy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Beta-Amyloid in Lewy body disease is related to Alzheimer\u0027s disease-like atrophy"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/47199", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-08-06"}, "publish_date": "2015-08-06", "publish_status": "0", "recid": "47199", "relation": {}, "relation_version_is_last": true, "title": ["Beta-Amyloid in Lewy body disease is related to Alzheimer\u0027s disease-like atrophy"], "weko_shared_id": -1}
Beta-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy
https://repo.qst.go.jp/records/47199
https://repo.qst.go.jp/records/47199a9c54147-3f5f-4c54-8a23-d544c5605150
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-08-06 | |||||
タイトル | ||||||
タイトル | Beta-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Shimada, Hitoshi
× Shimada, Hitoshi× Shinoto, Hitoshi× Hirano, Shigeki× Fukushi, Kiyoshi× Irie, Toshiaki× Ito, Hiroshi× Higuchi, Makoto× Suhara, Tetsuya× et.al× 島田 斉× 篠遠 仁× 平野 成樹× 福士 清× 入江 俊章× 伊藤 浩× 樋口 真人× 須原 哲也 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini–Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. | |||||
書誌情報 |
Movement Disorders 巻 28, 号 2, p. 169-175, 発行日 2012-12 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0885-3185 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://doi.wiley.com/10.1002/mds.25286 | |||||
関連名称 | http://doi.wiley.com/10.1002/mds.25286 |